Determining the association of medical co-morbidity with subjective and objective cognitive performance in an inner city memory disorders clinic: a retrospective chart review by Fischer, Corinne E et al.
RESEARCH ARTICLE Open Access
Determining the association of medical
co-morbidity with subjective and objective
cognitive performance in an inner city memory
disorders clinic: a retrospective chart review
Corinne E Fischer
1,4*†, Depeng Jiang
2†, Tom A Schweizer
3,4†
Abstract
Background: Medical co-morbidity may be associated with impaired cognitive function based on prior studies.
However, no studies to date have determined to what extent this association is linked to medical illness or other
factors that may be linked to medical illness (such as education, income levels, depression or subjective memory
loss). The present study examined how medical co-morbidity, socioeconomic status (defined as residential SES),
education and depression are associated with subjective and objective memory function in a sample of patients
recruited from a university affiliated Memory Disorders Clinic located in a large Canadian inner city teaching
hospital.
Methods: Data was collected from 85 consecutive referrals to an Inner City Memory Disorders Clinic including
socio-demographic characteristics, cognitive status and medical co-morbidity. Descriptive and correlational analyses
were conducted.
Results: Impaired objective cognitive function correlated significantly with increased medical co-morbidity and
partially with education but not with residential SES or depression. Elevated memory complaints correlated
significantly with depression, inversely with residential SES and not at all with medical co-morbidity or education.
Conclusions: Increased medical co-morbidity is significantly associated with impaired cognitive performance but
not with subjective memory complaints in an Inner City Memory Clinic sample.
Background
Increased medical co-morbidity is commonly associated
with the aging process [1,2]. There are many reasons for
this. For example, age is a risk factor for many common
diseases such as diabetes and chronic obstructive lung
disease. According to previous research, medical co-
morbidity rates tend to be higher among patients living
in large urban centres, often due to low socioeconomic
status and poorer access to health services [3]. High
rates of medical co-morbidity have also been found to
be associated with a number of adverse outcomes,
including impaired function in activities of daily living,
increased utilization of acute care services, and increased
mortality [2,4,5]. The question of the impact of medical
co-morbidity on cognitive function is a complex one. It
is generally known that having multiple medical disor-
ders may be associated with impaired brain function,
partly due to the direct neurotoxic effects of disease on
the brain and partly due to the possible neurotoxic
effects of medications used to treat these diseases [6].
Patients with low SES may be particularly at risk [7,8].
In spite of this common assertion, there have been few
studies that have systematically evaluated the impact of
medical co-morbidity on brain function and no studies
that have controlled for SES.
Of the existing studies that have examined the effect
of medical co-morbidity on cognitive function, the
majority have focused on objective function as opposed
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any medium, provided the original work is properly cited.to subjective function. Lyketsos et al (2005) [9] examined
a community sample and discovered medical co-morbid-
ity was much higher among individuals with dementia.
Cullum et al [10] examined a sample of older medical
inpatients and discovered a strong correlation between
medical co-morbidity and depression but surprisingly no
significant correlation with cognition. It is possible that
the lack of an association found in this study may be
attributable to the low sensitivity of the cognitive instru-
ment used (AMTS) in picking up changes in cognitive
functioning. Mariani et al [11] examined a sample of
patients with amnestic MCI (aMCI) and discovered cog-
nitive functioning was a strong predictor of IADL perfor-
mance while co-morbidity was not, possibly due to the
fact that traditionally changes in ADL performance are
more strongly linked to medical co-morbidity. Salvi et al
[12] examined a cohort of acutely ill medical inpatients
and found a strong correlation between medical co-mor-
bidity, cognitive functioning, length of stay, depression
and disability. Many studies have looked at the link
between medical co-morbidity and depression in older
adults, demonstrating a strong association [13-15]. How-
ever, no studies to date have explored how SES might
impact on this association.
Subjective memory loss may or may not correlate with
objective memory function based on previous research
[16,17]. What is clear is that depressive symptoms and
personality traits may mediate part of this discrepancy.
In other words, patients with depressive symptoms may
have elevated subjective memory complaints in the face
of normal cognition [18,19]. The opposite pattern (nor-
mal subjective memory complaints in the face of objec-
tive memory function) may be observed in patients with
poor frontal lobe function, such as patients with vascu-
lar dementia or advanced dementia [20,21]. Patients
with elevated medical co-morbidity are at risk on both
counts. First, medical co-morbidity has been found to
be associated with high levels of depression [13-15]. Sec-
ond, medical co-morbidity is often associated with
dementia and cognitive dysfunction [9].
The objective of this study was to examine the impact
of medical co-morbidity and other SES factors on sub-
jective and objective memory function in a sample of
patients with mixed diagnoses (dementia, MCI, normal
cognitive functioning) referred to a Memory Disorders
Clinic. As a result of it’s geographic location the clinic
sees patients with both high and low SES, making it an
ideal environment to study the effects of SES. Further-
more, patients are referred to the clinic by their family
doctor and/or specialist often with a complaint of mem-
ory loss but not necessarily objective findings. Thus, the
base rates of memory complaints tends to be high and it
provides an ideal opportunity for studying how SES and
associated factors may modify the relationship between
subjective and objective cognitive function in a memory
clinic setting. We hypothesized based on the literature
that patients referred to our Memory Clinic with low
SES, increased medical co-morbidity, low education, and
the presence of depression would be more likely to have
objective cognitive impairment but not necessarily sub-
jective memory loss.
Methods
Data from 85 patients aged 50 or above attending a
Memory Disorders Clinic located in a large urban centre
was examined retrospectively. The sample consisted of
community dwelling patients with a variety of diagnoses
(dementia, MCI, cognitively normal) referred by their
family physicians with a complaint of memory loss.
While patients were all medically stable many were on a
number of medications. The study was approved by the
St. Michaels Hospital Research Ethics Board.
Measures
Residential SES
We chose to define SES based on neighbourhood
income quintiles. Prior studies that have used residential
SES as opposed to personal SES have typically been
done on a much larger scale and have been used to
determine the effect of neighbourhood SES on the pre-
valence of dementia, etc. We elected to use residential
SES as opposed to personal SES (ie income levels) in
order to maximize our clinical sample. Neighbourhood
income quintiles were computed using existing census
data and divided the region of Toronto into five quin-
tiles. The quintiles ranged from one (lowest income) to
five (highest income) and for the purposes of analysis
we pooled the two lowest income groups and the three
highest income groups with an income less than
$35,000.00 being defined as the cut off for low versus
high. For the purposes of our study we have decided to
separate out education from SES.
Cumulative Illness Rating Scale (CIRS) [22]
Medical co-morbidity was measured using the cumula-
tive illness rating scale, geriatric version (CIRS-G). In this
scale the body is divided into 13 different systems corre-
sponding to 13 different organ areas. Based on the nature
of the illness a severity score is assigned ranging from
0 (no impairment) to 4 (severe impairment). Certain ill-
nesses that affect multiple organ systems may in some
circumstances be coded more than once. The total score
is then achieved by adding up the sub-scores for each
organ system and indicates overall medical burden.
Patient Assessment of Own Function (PAOF) [23]
Subjective memory complaints were measured using
the Patient Assessment of Own Function (PAOF) [23].
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a 33 item tool designed to measure subjective memory
complaints. It includes questions about a variety of cog-
nitive functions including memory, language and com-
munication, sensory motor skills and higher level
intellectual functions. Participants are asked to respond
while thinking about the last two months and to rate
their complaints on the 6 points scale. While it has not
been validated in older patients with dementia it has
been used in a number of cognitively impaired popula-
tions including those with psychiatric problems, HIV
patients and those with chronic medical illnesses.
Behavioural Neurology Assessment [24]
The BNA is a clinician administered cognitive test that
measures multiple cognitive domains including lan-
guage, attention, visual spatial function, naming and
executive function. It is scored out of 114, with the cut
off for dementia being low 80. It has been validated in
patients with dementia and has been demonstrated to
be superior to the MMSE in detecting dementia [24].
Folstein Mini-Mental Status Examination [25]
The MMSE is a measure of global memory function
[25]. It is scored out of 30 and measures a variety of
cognitive functions including recall, orientation, visual
spatial function, etc. It has been extensively used in
dementia trials, with the cut off for dementia being 26
or less.
Diagnosis of Dementia/Depression
A diagnosis of dementia was made following compre-
hensive assessment by a behavioural neurologist and
geriatric psychiatrist in accordance with DSM-IV cri-
teria. All patients had brain imaging and routine blood
work to rule out reversible causes of dementia as well as
cognitive testing using the BNA and MMSE. While cut
off scores were not routinely used, most patients with
dementia scored below 26 out of 30 on the MMSE or
below 80 on the BNA. Depression was diagnosed using
DSM-IV criteria following comprehensive assessment by
a geriatric psychiatrist.
Statistical methods
Continuous variables were summarized in the descrip-
tive analyses using the mean, standard deviation and
range. Categorical variables and ordinal variables were
summarized using the number (percent) in various cate-
gories. Spearman rank correlations were used to exam-
ine the impact of education, socioeconomic status,
depression and medical co-morbidity on subjective and
objective memory function.
To avoid problems with confounders we ran two addi-
tional analyses. The first was a repeat of the spearman
rank correlation analysis adjusting for the effects of age.
The second was a multivariable linear regression analy-
sis to determine if the effects remained when medical
co-morbidity was removed from the analyses. Statistical
analyses were performed using SAS Version 9.2 (SAS
Institute, Cary, NC). All p-values were two-tailed and a
p-value less than 0.05 was regarded as being significant.
Results
In terms of descriptive statistics (see Table 1), the mean
age of the sample was 69.2(10.0) years, the mean level
of education was 14.0(3.5) years and the mean CIRS
score was 5.2(2.9), suggesting most patients had more
than one chronic medical illness. Men and women were
equally represented in the sample, and 45% had symp-
toms compatible with major depression. SES status
based on residential income quintiles was evenly distrib-
uted across the subgroups. The mean MMSE score of
subjects was 27/30 and the mean BNA score was 90/
114. 22% of the sample was cognitively normal, 39%
were demented (Alzheimer’s disease, mixed dementia,
dementia with lewy bodies, frontal-temporal dementia),
30% had mild cognitive impairment (MCI) and 9% had
dementia secondary to some other cause (traumatic
brain injury, lyme disease, cancer).
Table 1 Sample characteristics (N = 85)
Characteristics N Mean (SD) Range
Age, in years 85 69.2(10.0) 50-89
Education, in years 84 14.0(3.5) 5-26
Cumulative Illness Rating 85 5.2(2.9) 0-12
Gender
Male 48 50%
Female 48 50%
Depression
Yes 38 44.70%
No 47 55.30%
Residential area SES
Missing 4 4.70%
Level 1 (low) 16 18.80%
Level 2 11 12.90%
Level 3 13 15.30%
Level 4 11 12.90%
Level 5 (high) 30 35.30%
Diagnosis
Normal 18 21.18%
Alzheimer’s Dementia 33 38.82%
Mild Cognitive Impairment 26 30.59%
Traumatic Brain Injury 2 2.35%
Other 6 7.06%
Behvioural Neurology Assessment 85 89.7(14.4) 59-111
Mini Mental State Examination Score 85 27(3) 16-30
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bidity as measured by the CIRS score correlated nega-
tively with the MMSE score (p < .001), BNA (p < .05)
and all BNA sub scores (see Table 2). Conversely there
was no correlation between medical co-morbidity and
subjective memory complaints as measured by the
PAOF (p > .05). Furthermore, there was no correlation
with any of the PAOF sub scores (p > .05). Education
correlated, as predicted, with cognition as measured by
the MMSE (p < .05), but surprisingly not with the
BNA or any of the sub scores. Residential SES corre-
lated negatively with overall subjective memory com-
plaints (p < .001), and with two sub scores, (memory
complaints (p < .001) and language complaints (p <
.01)) while it correlated positively with executive func-
tion (p < .01). Depression did not correlate signifi-
cantly with any measure of objective cognitive function
(p > .05) but positively with overall subjective general
complaints (p < .001), memory complaints (p < .001)
and language complaints (p < .05) with the exception
of complaints in motor function (p > .05). Given that
age may be a covariate or suppressor variable in the
analyses, we reran the spearman rank correlations ana-
lyses with age as a co-variate and the results were
similar except for a small change in the magnitude of
the observed associations. In addition, we conducted
multivariable linear regression to examine whether
depression or subjective memory complaints are asso-
ciated with objective memory/cognitive performance
after the effects of medical co-morbidity are removed.
We found no significant associations. We felt that it
was important to run these additional analyses to
ensure that the observed association between medical
co-morbidity and objective memory impairment was
not being driven by other confounders such as age,
depression or subjective memory loss.
Discussion
We had predicted based on prior research that changes
in objective cognitive function in our Memory Disorders
Clinic sample would correlate strongly with increased
medical co-morbidity, depression, low SES and low edu-
cation. Surprisingly, decreased objective memory func-
tion correlated strongly with only medical co-morbidity,
partially with education and not at all with residential
SES. Subjective memory complaints did correlate with
depression but not at all with medical co-morbidity and
inversely with residential SES.
Prior research has suggested that SES correlates
strongly with cognitive functioning [8]. It is possible in
our study, given that we used residential SES as opposed
to income levels as our measure of SES, that our sample
size was not sufficiently large to detect differences. The
weak link with education, however, is even more sur-
prising given that low levels of education have been
shown to be significantly associated with poor cognitive
functioning. Education did correlate mildly with
impaired objective memory performance as measured by
the MMSE but did not correlate with a more specific
measure of cognitive function, the BNA. Given that the
sample looked at is quite elderly, it is possible that years
of education is not a good proxy for level of intellectual
function. The inverse relationship between subjective
memory complaints and SES does suggest that patients
with low SES tend to complain more about their mem-
o r yf u n c t i o n ,t h eo p p o s i t et r e n df r o mw h a tw o u l db e
observed using the theory of cognitive reserve.
Our study suggested a strong correlation between
medical co-morbidity and objective memory function
but a poor correlation with subjective memory function
in our Memory Clinic sample. Thus, patients evaluated
in our clinic with significant medical issues are clearly at
risk for cognitive impairment. Subjective memory
Table 2 Bivariate correlations between outcome variables
Education years Residential area SES Cumulative illness rating Depression
Subjective general complaints -0.06 -0.37(***) 0.08 0.45(***)
Memory complaints -0.05 -0.41(***) 0.07 0.45(***)
Language/communication problem -0.08 -0.34(**) 0.03 0.25(*)
Complaints of motor difficulties -0.03 -0.09 0.07 0.12
Complaints of thinking 0.06 -0.18 0.15 0.42(***)
Mini-Mental state examination 0.28* 0.04 -0.31(***) -0.03
Behavioural Neurology Assessment (BNA) Total score 0.20 0.09 -0.26(*) 0.03
BNA Attention 0.10 0.08 -0.22(*) 0.14
BNA Memory 0.14 0.01 -0.28(*) 0.02
BNA verbal ability 0.20 0.07 -0.27(*) 0.02
BNA visuospatial function 0.15 0.05 -0.21(*) -0.03
BNA brain’s executive function 0.18 0.29(**) -0.29(**) 0.05
Table 2 presents the Spearman correlations between the independent variables (e.g., level of residential area SES) and outcome variables (e.g., subjective
complains and objective measures of cognitive abilities). Note: * p < .05, ** p < .01, *** p < .001.
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tion. Awareness of such brain dysfunction is important
as it may lead to the adoption of compensatory strate-
gies, including use of calendars, aids, etc, which may
enhance brain function. It may also make patients more
likely to seek help or perhaps go on medications (such
as cognitive enhancers) that may preserve their brain
function. Previous studies have examined subjective
memory complaints and have found a relatively poor
correlation between complaints and actual cognitive per-
formance [16,17]. This study contributes further to our
understanding of the link between subjective memory
complaints and objective memory function by demon-
strating that this lack of association persists even in the
context of significant medical illness.
It is interesting to speculate as to why subjective
memory complaints would be low in patients with ele-
vated medical co-morbidity, especially given the strong
correlation with reduced cognitive performance. One
potential explanation is that such patients may be so
preoccupied with issues regarding their physical health
that they have little awareness of cognitive issues. In
addition, it is possible that it may have something to do
w i t ht h et h e o r yo fc o g n i t i v er e s e r v e[ 2 6 ] .A c c o r d i n gt o
this theory, it is possible that patients with high medical
co-morbidity have low cognitive reserve to begin with
and therefore experience cognitive changes in a more
gradual way, resulting in poor awareness. Finally, it is
possible that the relationship between medical co-mor-
bidity and subjective memory complaints may be
mediated by some other correlate, such as low SES or
limited education. Our study in fact showed only a par-
tial correlation with education and a negative correlation
with SES, suggesting this is not likely the mechanism.
Interestingly approximately half of the patients in the
clinic studied had a diagnosis of dementia while half did
not. There is some evidence to suggest that patients
with more severe cognitive impairment may be more
inclined to underreport their cognitive impairment while
the opposite is true of patients with less severe cognitive
impairment. Thus, it is possible that diagnosis alone
may explain to some degree the observed associations.
Whatever the mechanism, the implications of these
research findings are apparent. Patients evaluated in our
Memory Disorders Clinic who are in a sense more
impaired medically are less likely to be aware of their
cognitive deficits, making them more vulnerable. Such
patients may be less likely to seek help or develop com-
pensatory strategies, resulting in elevated risk. At a clini-
cal level, it may mean that such patient with high levels
of medical co-morbidity need to be assessed differently,
perhaps screened more rigorously for the presence of
cognitive deficits, or the physician may need to make a
greater effort to contact collateral sources. Medication
compliance is an area where physicians need to be espe-
cially vigilant, as poor cognition may lead to poor com-
pliance, resulting in a greater burden of medical illness.
This study has a number of limitations which should
be discussed. First, all of the measurement scales used
have some limitations. Specifically, the PAOF has not
been validated in the elderly and the BNA is a compi-
lation of tests that has not been correlated with other
neuropsychological tests. However, the PAOF has been
used in other cognitively impaired populations and the
BNA has shown to be superior to the MMSE in
detecting dementia. The CIRS is a good attempt to
quantify medical co-morbidity but as with many scales
may not capture the full impact of medical illness.
Also, in our sample we looked at all patients and did
not stratify based on diagnosis (cognitively normal,
MCI, dementia) as we were more interested in looking
at the effects of medical co-morbidity on overall sub-
jective/objective memory function as opposed to diag-
nosis. Furthermore, the design of the study was cross
sectional as opposed to longitudinal, the sample size
was relatively small and patients were recruited from a
Memory Disorders clinic as opposed to the commu-
nity. Thus, the findings are not generalizable to other
clinical settings such as the community, family practice
setting, etc. Finally, while more sophisticated statistical
methodology could be used to analyze the relationship
between mood, medical co-morbidity and cognition we
feel such analyses goes beyond the current scope of
our paper given our sample size.
Conclusions
In spite of these limitations, this study raises a number
of issues that warrant further exploration. While it
is clear from our preliminary findings that medical
co-morbidity leads to low complaints and increased
cognitive dysfunction, the precise mechanism of this is
less clear. In addition, there are a number of health
policy implications of our findings. Patients with high
levels of medical co-morbidity should be screened
more carefully for the presence of cognitive impair-
ment and offered resources to help cope with this.
Future studies should examine what the potential
causes for our findings are and also look at how these
research findings can be applied.
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